Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Pancreatic and Gastrointestinal Tumor Registry and Tissue Collection (SPORE)

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2014 by University of Alabama at Birmingham
Sponsor:
Collaborator:
Information provided by (Responsible Party):
University of Alabama at Birmingham
ClinicalTrials.gov Identifier:
NCT00584363
First received: December 24, 2007
Last updated: June 1, 2014
Last verified: June 2014

December 24, 2007
June 1, 2014
June 2004
June 2015   (final data collection date for primary outcome measure)
To diagnose Pancreatic Cancer [ Time Frame: 5 years ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00584363 on ClinicalTrials.gov Archive Site
Preventing patient form being misdiagnosed [ Time Frame: 5 years ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Pancreatic and Gastrointestinal Tumor Registry and Tissue Collection
Pancreatic and Gastrointestinal Tumor Registry and Tissue Collection (UAB/UMN SPORE in Pancreatic Cancer)

The purpose of the study is to collect pancreatic tissue, blood and urine from adults to study pancreatic abnormalities.

The aim of the study is to standardize, collect and share pancreatic cancer related information, to be used for research purposes only by researchers from different participating institutions/centers.

Observational
Time Perspective: Cross-Sectional
Not Provided
Retention:   Samples With DNA
Description:

Specimens are frozen and stored

Non-Probability Sample

Adults 19 years of age or older, pancreatic cancer patients at the University of Alabam at Birmingham.

Pancreatic Cancer
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
600
June 2015
June 2015   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Person over 19 years of age, patient with a tissue-proven diagnosis of pancreatic cancer at the University of Alabama at Birmingham (UAB) University Hospital during the period, and cognitive ability to provide informed consent

Exclusion Criteria:

  • Person not 19 or older and have not had a tissue-proven diagnosis of pancreatic cancer.
Both
19 Years and older
No
Contact: Stacey Branham, RN, BSN (205) 975-9564 sbranham@uab.edu
Contact: Toni Seay, M.A. (205) 934-7332 tamartin@uab.edu
United States
 
NCT00584363
F040514008, #000185970, 2P50CA101955
Yes
University of Alabama at Birmingham
University of Alabama at Birmingham
National Cancer Institute (NCI)
Principal Investigator: Charles M Wilcox, MD University of Alabama at Birmingham
University of Alabama at Birmingham
June 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP